|
|
Volumn 39, Issue 12, 1999, Pages 1272-1276
|
|
Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
AZIMILIDE;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG SOLUTION;
DRUG TOLERABILITY;
DRUG URINE LEVEL;
HEART ATRIUM FIBRILLATION;
HEART ATRIUM FLUTTER;
HEART ATRIUM MUSCLE;
HEART MUSCLE CELL;
HEART VENTRICLE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PAROXYSMAL TACHYCARDIA;
POTASSIUM CURRENT;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 0033334319
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: 10.1177/00912709922012088 Document Type: Article |
|
Times cited : (11)
|
|
References (7)
|
